Issue
Alert me when new journal issues are available via or via
Editorial board page CO2 Full-Text PDF (43 KB)
HOT TOPIC
Bortezomib, a novel proteasome inhibitor, in the treatment of hematologic malignancies, 21 November 2005 Graham Jackson, Hermann Einsele, Phillippe Moreau, Jesus San Miguel pages 591-602 Abstract | Full Text | Full-Text PDF (239 KB)
LABORATORY-CLINIC INTERFACE
The emerging role of DNA repair proteins as predictive, prognostic and therapeutic targets in cancer, 21 November 2005 Srinivasan Madhusudan, Mark R. Middleton pages 603-617 Abstract | Full Text | Full-Text PDF (223 KB)
ANTI TUMOUR TREATMENT
Taxanes in the treatment of early breast cancer, 08 November 2005 Alistair E. Ring, Paul A. Ellis pages 618-627 Abstract | Full Text | Full-Text PDF (129 KB)
CONTROVERSY
The challenge of systematic reviews of diagnostic and staging studies in cancer, 13 October 2005 Gary H. Lyman, Benjamin Djulbegovic pages 628-639 Abstract | Full Text | Full-Text PDF (199 KB)
EVIDENCE-BASED ONCOLOGY
Radical prostatectomy for early prostate cancer improves long term survival, 15 November 2005 Shabbir M.H. Alibhai, Sven Gogov pages 640-643 Full Text | Full-Text PDF (79 KB)
Adding rituximab to cyclophosphamide, vincristine and prednisone increases time to treatment failure or progression in people with untreated stage III/IV follicular lymphoma, 15 November 2005 Michele Ghielmini pages 644-647 Full Text | Full-Text PDF (71 KB)
Adjuvant capecitabine is at least as effective as fluorouracil plus leucovorin for survival in people with resected stage III colon cancer, 15 November 2005 C. Lamberti, T. Sauerbruch, A Glasmacher pages 648-652 Full Text | Full-Text PDF (81 KB)
High-quality evidence in oncology from 19 May to 9 June 2005: A summary, 21 November 2005 Benjamin Djulbegovic, Liz Bickerdike pages 653-656 Full Text | Full-Text PDF (66 KB)
Copyright © 2010 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.